Results 71 to 80 of about 18,981 (120)

Sample Size Recalculation in Adaptive Group Sequential Study Designs for Comparing Restricted Mean Survival Times. [PDF]

Stat Med
Herrmann C, Blanche P.
europepmc   +1 more source

Testing for Sufficient Follow-Up in Survival Data With a Cure Fraction. [PDF]

Biom J
Yuen TP, Musta E.
europepmc   +1 more source

Considerations for Estimating Causal Effects of Informatively Timed Treatments. [PDF]

Epidemiology
Oganisian A.
europepmc   +1 more source

Modelling dependent censoring in time-to-event data using boosting copula regression. [PDF]

Lifetime Data Anal
Strömer A, Klein N, Van Keilegom I, Mayr A.   +3 more
europepmc   +1 more source

Impact of acute kidney injury in ≥65-year-old kidney donors on short- and long-term allograft outcomes. [PDF]

Front Med (Lausanne)
Bachmann Q, Nebl L, Basta A, Kälble F, Mahler CF, Ott M, Braunisch MC, Assfalg V, Heemann U, Dippon J, Renders L, Schwenger V, Echterdiek F.   +12 more
europepmc   +1 more source

Analysis of the time to breast cancer diagnosis in Cuba: an observational study. [PDF]

BMC Public Health
Koley T.
europepmc   +1 more source

Time to death and its predictors among under-five children with acute pneumonia: a Bayesian parametric survival analysis. [PDF]

Pneumonia (Nathan)
Marine BT, Mengistie DT.
europepmc   +1 more source

Sales characteristics of Pokémon trading cards: A prospective one-year field study. [PDF]

PLoS One
Heck J, Schormann S, Krichevsky B, Groh A, Pape T, Schröder S, Glahn A, Schumacher C, Westhoff MS.   +8 more
europepmc   +1 more source

Benchmarking progression-free survival ratio as primary endpoint in precision oncology clinical trials. [PDF]

NPJ Precis Oncol
Nichetti F, Hüllein J, du Rusquec P, Pleasance E, Chen L, Mock A, Horak P, Ambrosini P, Rota S, Niger M, Agnelli L, Tinè G, Edelmann D, Le Tourneau C, Laskin J, Pruneri G, Wang C, Hübschmann D, de Braud F, Fröhling S, Mariani L.   +20 more
europepmc   +1 more source

Reassessment of the Collaborative Normal-Tension Glaucoma Study: Statistical Evidence and Implications for Current Management. [PDF]

Ophthalmol Ther
Killer HE, Pircher A, Stekhoven DJ.
europepmc   +1 more source